Detection of pathogens by real-time PCR in adult patients with acute exacerbation of bronchial asthma

 
Yutaka Yoshi, Kenichiro ShimizuMiyuki MorozumiNaoko ChibaKimiko UbukataHironori UrugaShigeo HanadaHiroshi WakuiShunsuke MinagawaHiromichi HaraTakanori NumataKeisuke SaitoJun ArayaKatsutoshi NakayamaKazuma Kishi and Kazuyoshi Kuwano

Abstract

Background

Respiratory tract infection is a major cause of acute exacerbation of bronchial asthma (AEBA). Although recent findings suggest that common bacteria are causally associated with AEBA, a comprehensive epidemiologic analysis of infectious pathogens including common/atypical bacteria and viruses in AEBA has not been performed. Accordingly, we attempted to detect pathogens during AEBA by using real-time polymerase chain reaction (PCR) in comparison to conventional methods.

Methods

We prospectively enroled adult patients with AEBA from August 2012 to March 2014. Infectious pathogens collected in nasopharyngeal swab and sputum samples were examined in each patient by conventional methods and real-time PCR, which can detect 6 bacterial and 11 viral pathogens. The causal association of these pathogens with AEBA severity and their frequency of monthly distribution were also examined.

Results

Among the 64 enroled patients, infectious pathogens were detected in 49 patients (76.6%) using real-time PCR and in 14 patients (21.9%) using conventional methods (p < 0.001). Real-time PCR detected bacteria in 29 patients (45.3%) and respiratory viruses in 28 patients (43.8%). Haemophilus influenzae was the most frequently detected microorganism (26.6%), followed by rhinovirus (15.6%). Influenza virus was the significant pathogen associated with severe AEBA. Moreover, AEBA occurred most frequently during November to January.

Conclusions

Real-time PCR was more useful than conventional methods to detect infectious pathogens in patients with AEBA. Accurate detection of pathogens with real-time PCR may enable the selection of appropriate anti-bacterial/viral agents as a part of the treatment for AEBA.

Download PDF

(You must be logged in to add and reply comments)

Interasma on Twitter

Interasma Top story: Vitamin D, the Sunshine Supplement, Has Shadowy Money Behind It https://t.co/wOlRsBJDir, see more https://t.co/CpGiFuOOYd
3hreplyretweetfavorite
Interasma Interasma - Secondhand Smoke Exposure in Childhood and Adulthood in Relation to Adult Mortality Among Never Smokers https://t.co/OiRAEbm3ti
5hreplyretweetfavorite
Interasma Interasma - Age and African-American race impact the validity and reliability of the asthma control test in persist… https://t.co/uwJyO07bis
5hreplyretweetfavorite
Interasma RT @Aller_MD: Autoinjectors are in especially high demand as the new school year begins. Reports of a shortage of EpiPens have been surfaci…
16hreplyretweetfavorite
Interasma RT @Aller_MD: Top story: Child passive smoking 'increases chronic lung risk' - BBC News https://t.co/nga9azowZF, see more https://t.co/jgCe
16hreplyretweetfavorite

Editor: Juan C. Ivancevich, MD

Copyright © Interasma 2003-2017  •  Terms of Use  •  Privacy Policy  •  Contact Us  •  Sitemap

Powered by FREI SA

InterAsma